Images List Premium Download Classic

Cancer

Cancer-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Markers for detection of gastric cancer
Pacific Edge Limited
October 12, 2017 - N°20170292956

Early detection of tumors is a major determinant of survival of patients suffering from tumors, including gastric tumors. Members of the gtm gene family can be differentially expressed in gastric tumor tissue, and thus can be used as markers for the detection of gastric and other types of cancer. The present invention provides for novel gtms for the detection of ...
Methods and devices relating to the detection of oral cancer biomarkers
Ge Healthcare Uk Limited
October 12, 2017 - N°20170292954

Disclosed is an ex vivo method for detecting plural predefined oral biomarkers within biological material present in a human oral cavity when oral cancerous activity is present in said cavity, the method comprising the steps of: i) providing a solid support for accepting a sample of biological material from the oral cavity; ii) transferring a sample of the biological material ...
Kit for cancer detection
Lihpao Life Science Corp.
October 12, 2017 - N°20170292164

The present invention provides a primer set and a kit containing same for analyzing a sequence of an mlh1 dna, an mlh1 mrna, and/or a cdna sequence derived from said mlh1 mrna of a subject to identify a v384 alteration of an mlh1 gene encoded protein.
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method and means for typing a sample comprising cancer cells based on oncogenic signal transduction ...
Agendia N.v.
October 12, 2017 - N°20170292162

The invention is related to a method of determining whether an individual suffering from cancer is likely to respond to anti-egfr and/or egfr pathway therapy. In one aspect, the invention utilizes the expression level of a set of genes for determining said response. In a further aspect, the invention relates to a method of assigning treatment to an individual ...
Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers
Merrimack Pharmaceuticals, Inc.
October 12, 2017 - N°20170291957

Provided are methods of suppressing growth of triple negative breast tumors and basal-like breast tumors by contacting tumor cells with an erbb3 inhibitor, e. G., an anti-erbb3 antibody. Also provided are methods for treating triple negative breast cancer or basal-like breast cancer in a patient by administering to the patient an erbb3 inhibitor, e. G., an anti-erbb3 antibody. The treatment ...
Her3 inhibition in low-grade serous ovarian cancers
Merrimack Pharmaceuticals, Inc.
October 12, 2017 - N°20170291956

Methods of treatment of cancer are provided. In particular, methods of treatment of low-grade serous ovarian cancers by inhibiting signaling of an egfr family member are provided.
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Activation of adaptive immune processes for the treatment of cancers and infectious diseases
Susavion Biosciences, Inc.
October 12, 2017 - N°20170290922

Polypeptides, such as a multi-valent polypeptide designated svd2, useful in pharmaceutical compositions for stimulation of the adaptive arm of the immune system. Svd2 demonstrated in vivo activity in a syngeneic mouse model. Svd2 is biologically active at nanomolar concentrations. These properties are believed to result as a consequence of the ability of svd2 to cross-link cell-surface receptors.
Combination therapy comprising ox40 binding agonists and pd-1 axis binding antagonists
Genentech, Inc.
October 12, 2017 - N°20170290913

The invention provides compositions and methods for treating cancers. The method comprises administering a pd-1 axis binding antagonist and an ox40 binding agonist.
Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against ...
Immatics Biotechnologies Gmbh
October 12, 2017 - N°20170290897

The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated t-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor ...
Methods of treating prostate cancer with gnrh antagonist
Ferring B.v.
October 12, 2017 - N°20170290879

The invention provides methods and dosing regimens for safely and effectively treating androgen-dependent prostate cancer with a gonadotrophin releasing hormone (gnrh) antagonist without causing a testosterone spike and/or other side effect of gnrh agonist therapy such as a urinary tract infection, or an arthralgia-related or cardiovascular side effect.
Methods of treating cancer with tubulysin conjugates
Endocyte, Inc.
October 12, 2017 - N°20170290878

The invention described herein pertains to drug delivery conjugates for targeted therapy. The invention described herein relates to methods of treating folate receptor-expressing cancers with a folate-tubulysin conjugate. The invention described herein also relates to methods of treating folate-expressing cancers with a folate tubulysin conjugate in patients where stable disease results after treatment with the folate-tubulysin conjugate.
Therapeutic compositions and uses thereof
Manuka Health New Zealand Limited
October 12, 2017 - N°20170290865

This invention provides pharmaceutical compositions, including anti-gastrointestinal cancer compositions, containing propolis and cyclodextrin. Methods of using such compositions, in particular in the treatment or prevention of gastrointestinal cancers, and the resensitisation of gastrointestinal cancers to therapy are also provided.
Akt and shh pathway inhibitor combination therapy for treating basal cell carcinomas
The Trustees Of Columbia University In The City Of New York
October 12, 2017 - N°20170290849

A mechanism whereby aberrant shh signaling converges on the akt1-mtor pathway, conferring selective growth advantage and enhanced survival of tumor cells has been identified. Utilizing a mouse model of bcns, a pivotal role has been discovered for akt1 signaling in bcc tumorigenesis. Based on the results described here certain embodiments are directed to methods and pharmaceutical formulations for treating ...
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Arylquinazolines
Merck Patent Gmbh
October 12, 2017 - N°20170290836

The invention relates to novel compounds of the formula (i) which can be used for the inhibition of serine-threonine protein kinases and for the sensitisation of cancer cells to anticancer agents and/or ionising radiation.
Reducing tumor burden by administering ccr1 antagonists in combination with pd-1 inhibitors or pd-l1 inhibitors
Chemocentryx, Inc.
October 12, 2017 - N°20170290808

The present invention provides methods for reducing tumor burden, tumor growth, tumor progression, and/or metastasis in a subject suffering from a solid tumor cancer such as triple negative breast cancer. The methods include administering to a subject in need thereof a therapeutically effective amount of a pd-l1 inhibitor or a pd-1 inhibitor in combination with a small molecule chemokine ...
Combination therapy with an anti-hyaluronan agent and therapeutic agent
Halozyme, Inc.
October 12, 2017 - N°20170290796

Provided herein is combination cancer therapy effected by administering a polymer-conjugated hyaluronidase, and a tumor-targeted taxane, and optionally a further chemotherapeutic agent such as a nucleoside analog. The combination therapy can be used in methods of treating cancers, and in particular solid tumor cancers.
Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of ...
Hong Kong Baptist University
October 12, 2017 - N°20170290782

The present invention relates to a polyphenol derivative of the stilbenoid family, namely trans-3,5,4′-trihydroxybibenzyl, also known as dihydro-resveratrol, as a remedial agent. In particular, the present invention presents the usage of dihydro-resveratrol as an anti-fibrotic agent in suppressing the activation of pancreatic stellate cells (pscs). One embodiment of the present invention also relates to the management of pancreatic ...
Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
University Of Pittsburgh - Of The Commonwealth System Of Higher Education
October 12, 2017 - N°20170290773

The present invention provides pharmaceutical compositions and methods for the instillation of lipid vehicles comprised of liposomes containing sphingomyelin or sphingomyelin metabolites to prevent, manage, ameliorate and/or treat disorders involving neuropathic pain and aberrant muscle contractions, such as what occurs in bladder hyperactivity disorders such as interstitial cystitis (ic) in animals or humans in need thereof. Also provided is ...
Methods and systems for visualizing gene expression data
Koninklijke Philips N.v.
October 05, 2017 - N°20170286597

Methods and systems for visualizing gene expression data in a way that permits the comparison of different patient groups to facilitate medical applications, including cancer diagnostics and treatment planning, particularly breast cancer. The method organises gene expression data for at least one patient into a plurality of windows of a specified size, calculates an average rsem score for all of ...
Methods for predicting and improving the survival of gastric cancer patients
Pierian Holdings, Inc.
October 05, 2017 - N°20170285044

The present invention provides assays and methods for predicting the post-operative survival of a subject having an early stage gastric cancer after tumor surgery. The present invention also provides methods for treating a subject having an early stage gastric cancer by administering a combination therapy tailored to the signal transduction biomarkers that are activated in the cancer. In particular embodiments, ...
Methods for detecting ovarian cancer
Zora Biosciences Oy
October 05, 2017 - N°20170285036

The present description is related to the field of ovarian cancer diagnostics. It introduces novel biomarkers that can be used to detect presence of ovarian cancer and to provide a prognosis of the disease.
Loading